Clinical Trial Update: SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 trial SIMPLICITY evaluated liprotamase for malabsorption in cystic fibrosis-related exocrine pancreatic insufficiency; the study completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Liprotamase (liprotamase)

Snippet

Sponsor: Anthera Pharmaceuticals | Conditions: Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2018-05-11